We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Agena Bioscience

Agena Bioscience® empowers research laboratories worldwide to deliver scalable targeted genomic data. Our advanced pl... read more Featured Products: More products

Download Mobile App




Benchtop Multiplex Genetic Analyzer Helps Target, Identify, and Confirm Clinically Relevant Mutations

By LabMedica International staff writers
Posted on 17 Feb 2023
Print article
Image: MassARRAY benchtop system provides timely and accurate analysis of up to 1000s of samples in a single day (Photo courtesy of Agena Bioscience)
Image: MassARRAY benchtop system provides timely and accurate analysis of up to 1000s of samples in a single day (Photo courtesy of Agena Bioscience)

Laboratories are required to maintain an efficient lab workflow in order to ensure the integrity of results. Now, a benchtop multiplex genetic analyzer empowers high-throughput testing by automating key aspects of sample preparation while providing laboratories with the flexibility to customize their extraction and sample preparation protocols.

The MassARRAY Dx Analyzer from Agena Bioscience, Inc. (San Diego, CA, USA) is a benchtop multiplex genetic analyzer that simplifies the complex clinical genetics environment with easy-to-interpret data, flexible biomarker detection and robust performance. Placed at the center of the clinical workflow, laboratories can optimize throughput, turn-around-times, and data analysis. With their growing need for marker coverage, the MassARRAY System empowers laboratories to provide targeted patient diagnostics more quickly, ultimately resulting in faster treatment decisions.

The MassARRAY System workflow combines mass spectrometry with end-point PCR, enabling highly multiplexed reactions under universal cycling conditions. After nucleic acid extraction, approximately 10-40ng of sample advances through a simple workflow with easy steps. It uses matrix-assisted laser desorption/ionization - time of flight (MALDI-TOF) mass spectrometry for the precise detection of DNA molecules. It distinguishes genetic variants by analyzing their individual mass, thus eliminating the need for fluorescence or labeling.

The MassARRAY system and exclusive SpectroCHIP consumable allow laboratories to genotype up to 50 genetic variants on each pad: up to 19,200 genetic variants across the entire chip. The MassARRAY is an ideal system for targeting 10s-100s of genetic markers per sample. The SpectroCHIP features 96 or 384 inert matrix pads evenly spaced across an array. Unique DNA analyte mixtures can be deposited onto any pad, enabling side-by-side testing of different assays for distinct biomarkers from varying sample types in a single run. The MassARRAY can meet a laboratory's testing needs with pre-designed and custom panels across the molecular diagnostics industry, enabling detection of a wide range of biomarkers including SNPs, insertions, deletions, translocations, copy number variation, and methylation.

Related Links:
Agena Bioscience, Inc.

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Fixed Volume Pipettor
Labpette FX
New
Automated Nucleic Acid Extraction Instrument
EX9600

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The PAXgene Urine Liquid Biopsy Set is the first standardized preanalytical workflow that stabilizes cell-free DNA in urine for subsequent analysis (Photo courtesy of PreAnalytiX)

Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine

Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.